Lv2
170 积分 2023-07-04 加入
NEUROMYELITIS OPTICA SPECTRUM DISORDER IN LATIN AMERICA: a global data share initiative
9天前
已完结
Efficacy and safety of inebilizumab in Asian participants with neuromyelitis optica spectrum disorder: Subgroup analyses of the N-MOmentum study
9天前
已完结
Safety and efficacy of inebilizumab for the treatment of neuromyelitis optica spectrum disorder: end-of-study results from the open-label period of the N-MOmentum trial
9天前
已完结
A Phase 3 Trial of Inebilizumab in Generalized Myasthenia Gravis
9天前
已完结
Osimertinib after Chemoradiotherapy in Stage III EGFR -Mutated NSCLC
16天前
已完结
Outcomes in Relation to the Age at Onset in Patients With Myasthenia Gravis
16天前
已完结
Clinical characteristics and prognosis of very late-onset myasthenia gravis in China
16天前
已完结
Therapeutic and Immunoregulatory Effects of Tacrolimus in Patients with Refractory Generalized Myasthenia Gravis
17天前
已完结
Bortezomib, thalidomide, and dexamethasone with or without daratumumab before and after autologous stem-cell transplantation for newly diagnosed multiple myeloma (CASSIOPEIA): a randomised, open-label, phase 3 study
21天前
已完结
Efficacy and safety of telitacicept for myasthenia gravis in real-world practice and exploratory outcomes in the elderly subgroup
27天前
已完结
皖公网安备34019202002308
